Development of potent and selective Cathepsin C inhibitors free of aortic binding liability by application of a conformational restriction strategy-Reference-Cited by-同舟云学术

Development of potent and selective Cathepsin C inhibitors free of aortic binding liability by application of a conformational restriction strategy

Published:2021-09 Issue: Volume:47 Page:128202
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Banerjee Abhisek,Velagaleti Ranganadh,Patil Sandip,Pawar Mahesh,Yadav Pravin,Kadam Pradip,Qadri Mohammad Mohsin,Chakraborti Samitabh,Saini Jagmohan S.,Behera Dayanidhi B.,Karanjai Keya,Iyer Pravin S.,Gharat Laxmikant A.,Das Sanjib

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference40 articles.

1. Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases

2. Cathepsin C Inhibitors: Property Optimization and Identification of a Clinical Candidate

3. Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases

4. Therapeutic targeting of cathepsin C: from pathophysiology to treatment

5. Therapeutic Utility and Medicinal Chemistry of Cathepsin C Inhibitors

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. My 50-Plus Years of Academic Research Collaborations with Industry. A Retrospective;The Journal of Organic Chemistry;2024-06-12

2. Cysteine cathepsins: A long and winding road towards clinics;Molecular Aspects of Medicine;2022-12